Abstract
The study of economic issues relevant to oncology, death, and dying is – and should be – an important component of a multifaceted analysis of our healthcare system. This includes the analysis and design of practices and policies of healthcare providers and individual physician and patient-consumer decision-making processes.
Keywords
- Gross Domestic Product
- Moral Hazard
- Quality Adjusted Life Year
- Adverse Selection
- Health Insurance Program
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, access via your institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsNotes
- 1.
National health expenditures includes health consumption expenditure (inclusive of personal health care, administration and net cost of private health insurance, and public health spending), as well as investment in health care.
- 2.
Per OECD methodology, the United States spends 16.4 % of its GDP on healthcare in 2013, rather than 17.4 %, as calculated by the US National Center for Health Statistics.
- 3.
Direct medical costs of cancer treatment are generally U-shaped. The spikes in direct costs are associated with initial period following the diagnosis and end-of-life period; and direct costs are typically lowest in the period between the two, as in the case of colorectal cancers of varying survival rates (Yabroff et al. 2008).
References
AHIP Center for Policy and Research (2014) January 2014 census shows 17.4 million enrollees in Health Savings Account—eligible High Deductible Health Plans (HSA/HDHPs). America’s Health Insurance Plans, Washington, DC
Akerlof G (1970) The market for “lemons”: quality uncertainty and the market mechanism. Quart J Economics 84(3):488–500
Banks D (1998) The economics of death? A descriptive study of the impact of funeral and cremation costs on U.S. households. Death Stud 22(3):269–285
Centers for Medicare & Medicaid Services (2015) National health expenditure fact sheet. Retrieved from https://www.cms.gov/research-statistics-data-and-systems/statistics-trends-and-reports/nationalhealthexpenddata/nhe-fact-sheet.html
Centers for Medicare & Medicaid Services (2010) Statistics, trends, and reports: National health expenditure data. Retrieved from https://www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/NationalHealthExpendData/Downloads/2010GenderandAgeTables.pdf
Coast J (2014) Strategies for the economic evaluation of end-of-life care: making a case for the capability approach. Expert Rev Pharmacoecon Outcomes Res 14(4):473–482
Cropper ML, Hammitt JK, Robinson LA (2011) Valuing mortality risk reductions: progress and challenges, NBER Working Paper Series. National Bureau of Economic Research, Cambridge, MA, Retrieved from http://www.nber.org/papers/w16971.pdf
Fan JX, Zick CD (2004) The economic burden of health care, funeral, and burial expenditures at the end of life. Consum Aff 38(1):35–55
Field RI (2008) Why is health care regulation so complex? Pharm Therap 33(10):607–608
Gawande A (2014) Being mortal: medicine and what matters in the end. Metropolitan Books/MacMillan, New York
Gawande A (2015) Overkill. New Yorker
Kaiser Family Foundation (2014) 2014 Employer Health Benefits Survey. Retrieved from http://kff.org/report-section/ehbs-2014-summary-of-findings/
Kaiser Family Foundation (2015) Key facts about the uninsured population. Retrieved from http://kff.org/uninsured/fact-sheet/key-facts-about-the-uninsured-population/
Lyman GH (2007) Economics of cancer care. J Oncol Pract 3(3):113–114. doi:10.1200/JOP.0731501
Mariotto AB, Yabroff KR, Shao Y, Feuer EJ, Brown ML (2011) Projections of the cost of cancer care in the United States: 2010-2020. J National Cancer Inst 103:117–128
National Center for Health Statistics (2014) Health, United States, 2014: with special features on adults aged 55-64. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Hyattsville, Retrieved from http://www.cdc.gov/nchs/data/hus/hus14.pdf#103
National Funeral Directors Association (2015) Median cost of an adult funeral. NFDA, Brookfield, Retrieved from http://nfda.org/about-funeral-service-/trends-and-statistics.html
National Hospice and Palliative Care Organization (2015) NHPCO’s facts and figures: Hospice care in America (2015 ed.). NHPCO, Alexandria. Retrieved from http://www.nhpco.org/sites/default/files/public/Statistics_Research/2015_Facts_Figures.pdf
Nord E, Daniels N, Kamlet M (2009) QALYs: some challenges. Value Health 12:S10–S15. doi:10.1111/j.1524-4733.2009.00516.x
Organization for Economic Co-operation and Development (2015) OECD health statistics 2015: Frequently requested data. Retrieved from http://www.oecd.org/els/health-systems/health-data.htm
Riley GF, Lubitz JD (2010) Long-term trends in Medicare payments in the last year of life. Health Serv Res 45(2):565–576. doi:10.1111/j.1475-6773.2010.01082.x
Round J (2012) Is QALY still a QALY at the end of life? J Health Econ 31(3):521–527. doi:10.1016/j.jhealeco.2012.01.006
Soni A (2015a) Trends in the five most costly conditions among the U.S. Civilian Noninstitutionalized Population, 2002 and 2012. Statistical Brief #470. Agency for Healthcare Research and Quality, Rockville. Retrieved from http://www.meps.ahrq.gov/mepsweb/data_files/publications/st470/stat470.shtml
Soni A (2015b) Top five most costly conditions among adults age 18 and older, 2012: estimates for the U.S. Civilian Noninstitutionalized Population. Statistical Brief #471. Agency for Healthcare Research and Quality, Rockville. Retrieved from http://meps.ahrq.gov/mepsweb/data_files/publications/st471/stat471.shtml
Sun EC, Jena AB, Lakdawalla DN, Reyes CM, Philipson TJ, Goldman DP (2009) An economic evaluation of the war on cancer, NBER Working Paper Series. National Bureau of Economic Research, Cambridge, MA, Retrieved from http://www.nber.org/papers/w15574.pdf
Sun E, Jena AB, Lakdawalla D, Reyes CM, Philipson TJ, Goldman DP (2008) Relative contribution of better treatments and improved detection: an analysis of cancer survival gains from 1988-2000 using SEER data. RAND Corporation, Santa Monica
Uyl-de Groot CA (1995) Economic evaluation of cancer treatments. Thesis Erasmus Universiteit Rotterdam. Erasmus University Rotterdam, Rotterdam
Van Houtwen CH, Norton EC (2004) Informal care and health care use of older adults. J Health Econ 23(6):1159–1180. doi:10.1016/j.jhealeco.2004.04.008
Weinstein MC, Torrance G, McGuire A (2009) QALYs: the basics. Value Health 12:S5–S9. doi:10.1111/j.1524-4733.2009.00515.x
Yabroff KR, Lund J, Kepka D, Mariotto A (2011) Economic burden of cancer in the United States: estimates, projections, and future research. Cancer Epidemiol Biomarkers Prev 20(10):2006–2014
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Dolgopolov, V. (2017). Economic Aspects of Death and Dying in Oncology. In: Berk, L. (eds) Dying and Death in Oncology. Springer, Cham. https://doi.org/10.1007/978-3-319-41861-2_9
Download citation
DOI: https://doi.org/10.1007/978-3-319-41861-2_9
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-41859-9
Online ISBN: 978-3-319-41861-2
eBook Packages: MedicineMedicine (R0)